Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Centene Corp.

Start price
Target price
Perf. (%)
€68.85
29.04.24
€102.58
29.04.25
0.00%
29.04.24

Oppenheimer Holdings Inc. 
29.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€201.10
29.04.24
€251.56
29.04.25
0.00%
29.04.24

Oppenheimer Holdings Inc. 
29.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€201.10
29.04.24
€251.56
29.04.25
0.00%
29.04.24

Oppenheimer Holdings Inc. 
29.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€201.10
29.04.24
€251.56
29.04.25
0.00%
29.04.24

Oppenheimer Holdings Inc. 
29.04.24 50%
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€290.50
29.04.24
€341.93
29.04.25
0.00%
29.04.24

Barclays PLC 
29.04.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€148.94
29.04.24
€174.43
29.04.25
1.13%
29.04.24

Barclays PLC 
29.04.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€148.42
29.04.24
€168.07
29.04.25
1.48%
29.04.24

BMO Capital Markets 
29.04.24 50%
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€290.50
29.04.24
€307.19
29.04.25
0.00%
29.04.24

Royal Bank of Canada 
29.04.24 50%
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€287.80
29.04.24
€322.23
29.04.25
0.94%
29.04.24

Oppenheimer Holdings Inc. 
29.04.24 50%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.47%
29.04.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
ReynadJ 
28.04.24 0%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.47%
29.04.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
ReynadJ 
28.04.24 0%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.47%
29.04.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
ReynadJ 
28.04.24 0%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
0.85%
29.04.24

StockNews.com 
27.04.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
0.85%
29.04.24

StockNews.com 
27.04.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
0.85%
29.04.24

StockNews.com 
27.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
3.47%
29.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
3.47%
29.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
3.47%
29.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€80.16
26.04.24
€92.49
26.04.25
0.03%
29.04.24

Wells Fargo & Company 
26.04.24 50%
buy
Resmed Inc.

Start price
Target price
Perf. (%)
€202.80
26.04.24
€186.84
26.04.25
-0.15%
29.04.24

Oppenheimer Holdings Inc. 
26.04.24 50%
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€117.82
26.04.24
€149.55
26.04.25
-0.41%
29.04.24

Raymond James 
26.04.24 50%
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€117.82
26.04.24
€149.55
26.04.25
-0.41%
29.04.24

Raymond James 
26.04.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.35
26.04.24
€79.45
26.04.25
0.34%
29.04.24

TD Cowen 
26.04.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.35
26.04.24
€79.45
26.04.25
0.34%
29.04.24

TD Cowen 
26.04.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.35
26.04.24
€79.45
26.04.25
0.34%
29.04.24

TD Cowen 
26.04.24 50%